VN1R36P

Q-omics provides the consensus-scored VN1R36P profile across patient tissues and cancer cell-line models. VN1R36P expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, VN1R36P RNA expression shows 7,348 significant gene co-expression associations, with the highest sampling consensus in LUSC. Together, these results highlight BLCA, and LUSC as cancer lineages where VN1R36P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes VN1R36P survival associations across molecular data types. VN1R36P RNA expression shows survival associations in the most cancer types (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

VN1R36P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	2	BLCA (36)	view →

This table ranks reproducible VN1R36P RNA expression–survival associations across cancer types. High VN1R36P expression shows unfavorable associations in BLCA and ACC. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .002). Together, the overview and detailed table identify BLCA as the clearest survival context for VN1R36P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	IV	0.109	0.480	.002	36	view →
ACC	DFS	Tertile	All	0.195	0.748	.003	9	view →

Pink = unfavorable, green = favorable. all 2 lineages →

VN1R36P-BLCA (DFS)

Explore this curve interactively →